InvestorsHub Logo

Black-Ops

09/26/21 7:53 PM

#186308 RE: ClosetInvestor #186305

I five years we will see who is correct. Call it nonsense. That makes my day.

Buddyboy20

09/26/21 7:56 PM

#186309 RE: ClosetInvestor #186305

"He goes for the lowest hanging fruit (and the least amount of money) hoping for an EUA or BTD and he sells it to shareholders in that manner."

Now that sounds like good business sense. Going after low hanging fruit that can add the quickest, and highest, value to our product. Nice job of explaining the dynamics of Cytodyn, Leronlimab, and Nader Pourhassan.

misiu143

09/26/21 8:08 PM

#186311 RE: ClosetInvestor #186305

Dr Harish , Dr Lalezari , Dr Yang , asking FDA for 4 doses for CD12 was not a miserable team , but a top line of a doctors who treated patients with Leronlimab , and knew what they are talking about , in contrary to FDA ..

But this is only imo ..

Leronlimab4DaWin

09/27/21 6:54 AM

#186337 RE: ClosetInvestor #186305

Has anyone for a second thought that it might not be NP, the protocol, or the FDA? Has anyone thought maybe, just maybe, the drug sucks?